Literature DB >> 3202165

Peripheral metabolism of PTH: fate of biologically active amino terminus in vivo.

F R Bringhurst1, A M Stern, M Yotts, N Mizrahi, G V Segre, J T Potts.   

Abstract

Clearance of intact parathyroid hormone (PTH) from blood is associated with rapid uptake by liver and kidney, limited proteolysis by tissue endopeptidases and, within minutes, appearance of circulating carboxyl-(COOH)-terminal PTH fragments. The fate of the corresponding amino(NH2)-terminal portion of the hormone during this peripheral metabolism is still unknown, however. To determine this, we have employed [35S]bovine PTH (bPTH) labeled to high specific activity at NH2-terminal methionines, which permits direct monitoring of the fate of the PTH NH2-terminus during metabolism in vivo. The [35S]PTH was administered by bolus or continuous intravenous infusion to anesthetized normal rats, to rats subjected to acute ablation of the liver, the kidneys, or both, and to rats receiving co-infusions of excess synthetic bPTH(1-34) NH2-terminal fragments. Analysis by high-resolution chromatographic techniques sensitive to 10(-13) M [35S]PTH peptides in plasma yields no evidence that peripheral metabolism of PTH generates circulating NH2-terminal fragments, even when special measures are taken to block clearance of such putative fragments from blood. We find that the NH2-terminus of PTH is rapidly degraded in situ by the liver but that both liver and especially kidney nevertheless contain low levels of NH2-terminal PTH fragments that, although not released into the blood, are large enough to be potentially active. Thus, the peripheral metabolism of PTH in normal animals does not normally lead to the formation of circulating amino terminal fragments of the hormone that might act independently of intact PTH on peripheral target tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202165     DOI: 10.1152/ajpendo.1988.255.6.E886

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist.

Authors:  Ross W Cheloha; Tomoyuki Watanabe; Thomas Dean; Samuel H Gellman; Thomas J Gardella
Journal:  ACS Chem Biol       Date:  2016-08-17       Impact factor: 5.100

Review 2.  Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

Authors:  Donovan Tay; Serge Cremers; John P Bilezikian
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

Review 3.  High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.

Authors:  Candice Z Ulmer; Kittrawee Kritmetapak; Ravinder J Singh; Hubert W Vesper; Rajiv Kumar
Journal:  J Am Soc Nephrol       Date:  2022-04-08       Impact factor: 14.978

4.  Immunoheterogeneity of parathyroid hormone pre- and postoperatively in primary hyperparathyroidism.

Authors:  A Bergenfelz; S Valdermarsson; B Ahrén
Journal:  Langenbecks Arch Chir       Date:  1995

Review 5.  Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.

Authors:  Kittrawee Kritmetapak; Chatlert Pongchaiyakul
Journal:  Int J Nephrol       Date:  2019-09-17

6.  Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure.

Authors:  Kittrawee Kritmetapak; Louis A Losbanos; Jolaine M Hines; Katherine L O'Grady; Candice Z Ulmer; Hubert W Vesper; Felicity T Enders; Ravinder J Singh; Rajiv Kumar
Journal:  Clin Chem       Date:  2021-06-01       Impact factor: 8.327

7.  Short carboxyl terminal parathyroid hormone peptides modulate human parathyroid hormone signaling in mouse osteoblasts.

Authors:  Kittrawee Kritmetapak; Ravinder J Singh; Theodore A Craig; Jolaine M Hines; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2021-07-28       Impact factor: 3.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.